Serum Anti-Müllerian Hormone: A Potential Biomarker for Polycystic Ovary Syndrome
September 2023
in “
International Journal of Microbiology Research
”
Studysummary This study suggests that anti-Müllerian hormone (AMH) is the most promising biomarker for diagnosing polycystic ovary syndrome (PCOS), especially in women with phenotype A and D.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer